EGFR and glioblastoma: The contemporary model of glioblastoma pathogenesis therefore assumes a tight correlation between genetic mutations (EGFR, PTEN, TP53, TERT), epigenetics, and microenvironmental niches, which synergistically define tumor biology, aggressiveness, recurrence potential, and treatment resistance.